| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |